secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2026-01-09T23:59:59+00:00
Accession:  0000313143-26-000003
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics acquires Vivasure Medical for up to €185M; upfront €100M plus €85M earn-out
--------------------------------------------------------------------------------

- Acquired all equity of Vivasure Medical, a Galway, Ireland-based developer of percutaneous vessel closure technology.
- Upfront consideration of €100M, net €52M after deducting prior investments and loans.
- Up to €85M in contingent consideration tied to sales growth and other milestones.
- Transaction funded with available cash on hand.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314326000003/0000313143-26-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314326000003/hae-20260109.htm
  HTML page:      https://secwatch.observer/filing/0000313143-26-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer